References in periodicals archive ?
In the next phase of marketing, Medsite Pharmaceutical Services will target approximately 14,000 high value physicians, including the remaining 85 percent of Dyrenium prescribers, as determined by Medsite's predictive modeling and physician profiling capabilities.
We are very pleased with the physician exposure that Medsite Pharmaceutical Services' gain share program has generated for Dyrenium," said Dr.